• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辅助机械通气患者中 SARS-CoV2 感染和多药耐药菌合并感染的动力学。

Dynamics of SARS-CoV2 Infection and Multi-Drug Resistant Bacteria Superinfection in Patients With Assisted Mechanical Ventilation.

机构信息

Microbiology Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.

Pharmacology Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.

出版信息

Front Cell Infect Microbiol. 2021 Aug 12;11:683409. doi: 10.3389/fcimb.2021.683409. eCollection 2021.

DOI:10.3389/fcimb.2021.683409
PMID:34458159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8387578/
Abstract

OBJECTIVE

To investigate the presence of bacteria and fungi in bronchial aspirate (BA) samples from 43 mechanically ventilated patients with severe COVID-19 disease.

METHODS

Detection of SARS-CoV-2 was performed using Allplex 2019-nCoV assay kits. Isolation and characterisation of bacteria and fungi were carried out in BA specimens treated with 1X dithiothreitol 1% for 30 min at room temperature, using standard culture procedures.

RESULTS

Bacterial and/or fungal superinfection was detected in 25 out of 43 mechanically ventilated patients, generally after 7 days of hospitalisation in an intensive care unit (ICU). Microbial colonisation (colony forming units (CFU) <1000 colonies/ml) in BA samples was observed in 11 out of 43 patients, whereas only 7 patients did not show any signs of bacterial or fungal growth. was identified in 17 patients. Interestingly, 11 out of these 17 isolates also showed carbapenem resistance. The molecular analysis demonstrated that resistance to carbapenems was primarily related to OprD mutation or deletion. was the second most isolated pathogen found in 13 samples, of which 8 were carbapenemase-producer strains.

CONCLUSION

These data demonstrate the detection of bacterial superinfection and antimicrobial resistance in severe SARS-CoV-2-infected patients and suggest that bacteria may play an important role in COVID-19 evolution. A prospective study is needed to verify the incidence of bacterial and fungal infections and their influence on the health outcomes of COVID-19 patients.

摘要

目的

调查 43 例重症 COVID-19 机械通气患者支气管吸出物(BA)样本中细菌和真菌的存在情况。

方法

使用 Allplex 2019-nCoV 检测试剂盒检测 SARS-CoV-2。BA 标本用 1X 二硫苏糖醇 1%室温孵育 30 分钟处理,采用标准培养程序分离和鉴定细菌和真菌。

结果

在 43 例机械通气患者中,有 25 例患者检测到细菌和/或真菌感染,通常在 ICU 住院 7 天后发生。在 43 例患者中的 11 例患者的 BA 样本中观察到微生物定植(菌落形成单位(CFU)<1000 个菌落/ml),而只有 7 例患者未显示任何细菌或真菌生长迹象。在 17 例患者中鉴定出。有趣的是,在这 17 个分离株中,有 11 个也表现出对碳青霉烯类药物的耐药性。分子分析表明,对碳青霉烯类药物的耐药性主要与 OprD 突变或缺失有关。是在 13 个样本中发现的第二种最分离的病原体,其中 8 个是产碳青霉烯酶的菌株。

结论

这些数据表明,在严重的 SARS-CoV-2 感染患者中检测到细菌的继发感染和抗生素耐药性,提示细菌可能在 COVID-19 演变中发挥重要作用。需要进行前瞻性研究以验证细菌和真菌感染的发生率及其对 COVID-19 患者健康结局的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9061/8387578/d5afa9dcbd32/fcimb-11-683409-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9061/8387578/301d30035c47/fcimb-11-683409-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9061/8387578/d5afa9dcbd32/fcimb-11-683409-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9061/8387578/301d30035c47/fcimb-11-683409-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9061/8387578/d5afa9dcbd32/fcimb-11-683409-g002.jpg

相似文献

1
Dynamics of SARS-CoV2 Infection and Multi-Drug Resistant Bacteria Superinfection in Patients With Assisted Mechanical Ventilation.辅助机械通气患者中 SARS-CoV2 感染和多药耐药菌合并感染的动力学。
Front Cell Infect Microbiol. 2021 Aug 12;11:683409. doi: 10.3389/fcimb.2021.683409. eCollection 2021.
2
Prevalence and Impact on Mortality of Colonization and Super-Infection by Carbapenem-Resistant Gram-Negative Organisms in COVID-19 Hospitalized Patients.COVID-19 住院患者中耐碳青霉烯类革兰氏阴性菌定植和继发感染的流行情况及其对死亡率的影响。
Viruses. 2023 Sep 15;15(9):1934. doi: 10.3390/v15091934.
3
Respiratory Bacterial and Fungal Superinfections During the Third Surge of the COVID-19 Pandemic in Iran.伊朗新冠疫情第三次高峰期间的呼吸道细菌和真菌二重感染
Microb Drug Resist. 2023 Mar;29(3):104-111. doi: 10.1089/mdr.2022.0227. Epub 2023 Jan 4.
4
Bacterial profiles and their antibiotic resistance background in superinfections caused by multidrug-resistant bacteria among COVID-19 ICU patients from southwest Iran.伊朗西南部 COVID-19 ICU 患者中多重耐药菌引起的继发感染的细菌谱及其抗生素耐药背景。
J Med Virol. 2023 Jan;95(1):e28403. doi: 10.1002/jmv.28403.
5
Bacterial and fungal ventilator associated pneumonia in critically ill COVID-19 patients during the second wave.危重症 COVID-19 患者在第二波疫情期间发生的细菌性和真菌性呼吸机相关性肺炎。
J Infect Public Health. 2021 Oct;14(10):1375-1380. doi: 10.1016/j.jiph.2021.08.003. Epub 2021 Aug 8.
6
Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU.评估 ICU 收治的 COVID-19 患者呼吸道的细菌合并感染。
BMC Infect Dis. 2020 Sep 1;20(1):646. doi: 10.1186/s12879-020-05374-z.
7
Rapid Detection of Bacterial and Fungal Pathogens Using the T2MR versus Blood Culture in Patients with Severe COVID-19.采用 T2MR 技术与血培养相比,用于检测重症 COVID-19 患者的细菌和真菌病原体的快速检测。
Microbiol Spectr. 2022 Jun 29;10(3):e0014022. doi: 10.1128/spectrum.00140-22. Epub 2022 Jun 13.
8
Co-Infections in Critically Ill Patients with or without COVID-19: A Comparison of Clinical Microbial Culture Findings.危重症 COVID-19 患者与非 COVID-19 患者的合并感染:临床微生物培养结果比较。
Int J Environ Res Public Health. 2021 Apr 20;18(8):4358. doi: 10.3390/ijerph18084358.
9
State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.COVID-19 肺炎患者继发肺部感染的研究进展。
Infection. 2021 Aug;49(4):591-605. doi: 10.1007/s15010-021-01602-z. Epub 2021 Mar 11.
10
The changing pattern of bacterial and fungal respiratory isolates in patients with and without COVID-19 admitted to intensive care unit.在入住重症监护病房的 COVID-19 患者和非 COVID-19 患者中,细菌和真菌呼吸道分离株的变化模式。
BMC Infect Dis. 2022 Feb 23;22(1):185. doi: 10.1186/s12879-022-07176-x.

引用本文的文献

1
Evaluation of Acinetobacter baumannii, Klebsiella pneumoniae, and Staphylococcus aureus respiratory tract superinfections among patients with COVID-19 at a tertiary-care hospital in Tehran, Iran.评价伊朗德黑兰一家三级医院 COVID-19 患者中鲍曼不动杆菌、肺炎克雷伯菌和金黄色葡萄球菌呼吸道合并感染的情况。
Eur J Med Res. 2023 Sep 2;28(1):314. doi: 10.1186/s40001-023-01303-3.
2
Kinetics of CD169, HLA-DR, and CD64 expression as predictive biomarkers of SARS-CoV2 outcome.CD169、HLA-DR和CD64表达动力学作为新冠病毒感染结果的预测生物标志物
J Anesth Analg Crit Care. 2023 Mar 27;3(1):6. doi: 10.1186/s44158-023-00090-x.
3
Coinfections in intensive care units. Has anything changed with Covid-19 pandemia?

本文引用的文献

1
Deciphering the state of immune silence in fatal COVID-19 patients.解读重症 COVID-19 患者的免疫沉默状态。
Nat Commun. 2021 Mar 5;12(1):1428. doi: 10.1038/s41467-021-21702-6.
2
Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: A review.测量血清细胞因子水平作为成人和儿童 COVID-19 病例炎症生物标志物的临床意义:综述。
Cytokine. 2021 Jun;142:155478. doi: 10.1016/j.cyto.2021.155478. Epub 2021 Feb 23.
3
Role of Host Immune and Inflammatory Responses in COVID-19 Cases with Underlying Primary Immunodeficiency: A Review.
重症监护病房的合并感染。随着新冠疫情的出现,情况有变化吗?
Acta Biomed. 2023 Jun 14;94(3):e2023075. doi: 10.23750/abm.v94i3.13429.
4
Crosslink between SARS-CoV-2 replication and cystic fibrosis hallmarks.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)复制与囊性纤维化特征之间的交联。
Front Microbiol. 2023 May 11;14:1162470. doi: 10.3389/fmicb.2023.1162470. eCollection 2023.
5
COVID-19 association with multidrug-resistant bacteria superinfections: Lessons for future challenges.新型冠状病毒肺炎与多重耐药菌二重感染:应对未来挑战的经验教训
Exp Ther Med. 2023 Apr 18;25(6):254. doi: 10.3892/etm.2023.11953. eCollection 2023 Jun.
6
Bacterial coinfection and antibiotic resistance in hospitalized COVID-19 patients: a systematic review and meta-analysis.COVID-19 住院患者的细菌合并感染和抗生素耐药性:系统评价和荟萃分析。
PeerJ. 2023 Apr 26;11:e15265. doi: 10.7717/peerj.15265. eCollection 2023.
7
Gram-negative ESKAPE bacteria bloodstream infections in patients during the COVID-19 pandemic.在 COVID-19 大流行期间,革兰氏阴性 ESKAPE 细菌血流感染患者。
PeerJ. 2023 Mar 29;11:e15007. doi: 10.7717/peerj.15007. eCollection 2023.
8
Investigation of antimicrobial resistance patterns and molecular typing of Pseudomonas aeruginosa isolates among Coronavirus disease-19 patients.研究冠状病毒病-19 患者中铜绿假单胞菌分离株的抗菌药物耐药模式和分子分型。
BMC Microbiol. 2023 Mar 29;23(1):84. doi: 10.1186/s12866-023-02825-w.
9
Bacterial profiles and their antibiotic resistance background in superinfections caused by multidrug-resistant bacteria among COVID-19 ICU patients from southwest Iran.伊朗西南部 COVID-19 ICU 患者中多重耐药菌引起的继发感染的细菌谱及其抗生素耐药背景。
J Med Virol. 2023 Jan;95(1):e28403. doi: 10.1002/jmv.28403.
10
The health facility as a risk factor for multidrug-resistant gram-negative bacteria in critically ill patients with COVID-19.医疗机构成为 COVID-19 重症患者耐多药革兰氏阴性菌的危险因素。
Clinics (Sao Paulo). 2022 Oct 17;77:100130. doi: 10.1016/j.clinsp.2022.100130. eCollection 2022.
宿主免疫和炎症反应在伴有基础原发性免疫缺陷的 COVID-19 病例中的作用:综述。
J Interferon Cytokine Res. 2020 Dec;40(12):549-554. doi: 10.1089/jir.2020.0210.
4
Co-infections: potentially lethal and unexplored in COVID-19.合并感染:在新冠病毒病中可能致命且未被探索。
Lancet Microbe. 2020 May;1(1):e11. doi: 10.1016/S2666-5247(20)30009-4. Epub 2020 Apr 24.
5
Bacterial co-infections with SARS-CoV-2.细菌合并感染 SARS-CoV-2。
IUBMB Life. 2020 Oct;72(10):2097-2111. doi: 10.1002/iub.2356. Epub 2020 Aug 8.
6
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.COVID-19 住院患者合并感染和再感染的发生率:一项回顾性队列研究。
Clin Microbiol Infect. 2021 Jan;27(1):83-88. doi: 10.1016/j.cmi.2020.07.041. Epub 2020 Jul 31.
7
Bat-borne virus diversity, spillover and emergence.蝙蝠携带病毒的多样性、溢出和出现。
Nat Rev Microbiol. 2020 Aug;18(8):461-471. doi: 10.1038/s41579-020-0394-z. Epub 2020 Jun 11.
8
Antimicrobial resistance in the age of COVID-19.新冠疫情时代的抗菌药物耐药性
Nat Microbiol. 2020 Jun;5(6):779. doi: 10.1038/s41564-020-0739-4.
9
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.细菌和真菌合并感染冠状病毒的个体:一项支持 COVID-19 抗菌药物处方的快速综述。
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468. doi: 10.1093/cid/ciaa530.
10
Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China.中国武汉 221 例 COVID-19 患者的临床特征和短期预后。
J Clin Virol. 2020 Jun;127:104364. doi: 10.1016/j.jcv.2020.104364. Epub 2020 Apr 9.